Clinical Trials
539 trialsdOCT-pBCC
Vejle Hospital
CARADERM
University Hospital, Lille
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
A Registry for People With T-cell Lymphoma
Memorial Sloan Kettering Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
Xijing Hospital
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Raman Spectroscopy and Skin Cancer
Stony Brook University
Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery
Memorial Sloan Kettering Cancer Center
AI-enhanced OCT Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma
Henry Ford Health System
BASIX
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
iCaRe2
University of Nebraska
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
M.D. Anderson Cancer Center
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Northwestern University
Skin Cancer Diagnostics Using Photoacoustic Imaging
Region Skane
TUPRO
University of Zurich
Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash
Northwestern University
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
Dana-Farber Cancer Institute
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ctDNA for Early Detection of Recurrence in Melanoma
Herlev and Gentofte Hospital
CER
Cancer Support Community, Research and Training Institute, Philadelphia
SJFAMILY
St. Jude Children's Research Hospital
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
M.D. Anderson Cancer Center
PROQEM
Leiden University Medical Center
HELIOPREDICT
Nantes University Hospital
ctDNA for Risk Stratification in Melanoma
Herlev and Gentofte Hospital
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
iSITE
The Wellcome Sanger Institute
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
Ohio State University Comprehensive Cancer Center
Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Hôpital NOVO
ctDNA in Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary
RELI
Maastricht University Medical Center
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
COSMIC
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
ELEPHAS-04
Mayo Clinic
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Mayo Clinic
IMMUMELA
Assistance Publique - Hôpitaux de Paris
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Institute of Oncology Ljubljana
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
FIBIOME
University Hospital, Grenoble
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine